Northwind Pharmaceuticals LLC recalls Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-
Recalled May 3, 2023 · FDA recall D-0553-2023 · Northwind Pharmaceuticals
Hazard
CGMP Deviations · FDA Class II
Units
a)164 bottles; b) 198 bottles
Sold at
Nationwide with the United States
Description
CGMP Deviations
Product
Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-54), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.
Manufacturer(s)
Northwind Pharmaceuticals LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →